#chikungunya — Wednesday, April 01, 2026 (1 items)
| 0 | 💬 0 |
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-04-01 | #vaccination #clinical trial #immunogenicity #live-attenuated #chikungunya |